-
Avicanna Secures US Patent For Topical Cannabinoid Technology To Treat Pain And Inflammation
Tuesday, August 27, 2024 - 2:54pm | 428Avicanna Inc. (OTCQX:AVCNF), a leading biopharmaceutical company specializing in plant-derived cannabinoid-based products, has announced the issuance of U.S. Patent No. US 20230025693A1 by the United States Patent and Trademark Office (USPTO). This patent covers Avicanna's deep penetrating topical...
-
First-Ever Human Trial Finds CBG Reduces Anxiety And Boosts Memory
Thursday, August 1, 2024 - 9:34pm | 446A recent clinical trial has identified potential therapeutic benefits of cannabigerol (CBG), a cannabinoid that has not been as widely studied as THC or CBD. The study, conducted by researchers at Washington State University (WSU) and the University of California, Los Angeles (UCLA), indicates...
-
Avicanna Exports Cannabinoids To Singapore Legally — Even Though Cannabis Is Punishable By Death In The Country
Thursday, July 11, 2024 - 1:28pm | 735Cannabinoid-focused biopharmaceutical company Avicanna Inc. (TSX:AVCN) (OTCQX:AVCNF) (FSE: 0NN) announced on Thursday that it has completed the commercial export of Aureus-branded purified cannabigerol (CBG) products into Singapore through its majority-owned subsidiary Santa Marta Golden Hemp. The...
-
Company Exploring CBG Production Signals New Era Of Commercial Success In Synthetic Biology
Wednesday, January 10, 2024 - 3:38pm | 668Biotech company Willow Biosciences Inc. (TSX:WLLW) (OTCQB:CANSF) generated nearly $1.3 million in revenues in 2023, increasing approximately 60% over the period. Dr. Chris Savile, president and CEO of the company called 2023 a "transformative year for Willow," which relies on synthetic biology...
-
Willow Biosciences Announces Q2 2021 Results, Agrees To Supply Cellular Goods With CBG
Monday, August 9, 2021 - 9:35am | 336Canadian biotechnology company Willow Biosciences Inc. (CSE: WLLW) (OTCQX: CANSF) reported its financial and operational results Monday for the three and six months ended June 30, revealing it has wrapped up its first commercial agreement cannabigerol over the period. In June, the Vancouver-based...
-
Cannabis Movers & Shakers: Next Green, Cannabis Control Commission, Willow, TruTrace, HEXO, Bengal Capital, MediPharm Labs, NIHC
Friday, January 15, 2021 - 11:57am | 1222Here is a summary of the latest leadership changes within the cannabis industry. Next Green Wave Announces Management Promotions Next Green Wave Holdings Inc. (CSE: NGW) (OTCQX: NXGWF) reported management shake-ups alongside its fourth-quarter financial results. The Vancouver-based company...
-
Kannaway Makes Its Debut On European CBG Market
Thursday, December 10, 2020 - 2:23pm | 267Kannaway made its debut on the European cannabigerol (CBG) market on Thursday by its parent company Medical Marijuana Inc. (PINK: MJNA). The move comes on the heels of Kannnaway's entering into the U.S. cannabinol market with the introduction of two new CBN isolate products...